ATYR
Price
$5.31
Change
-$0.03 (-0.56%)
Updated
Aug 7, 12:37 PM (EDT)
Capitalization
475.28M
6 days until earnings call
BIORQ
Price
$0.12
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Capitalization
N/A
Interact to see
Advertisement

ATYR vs BIORQ

Header iconATYR vs BIORQ Comparison
Open Charts ATYR vs BIORQBanner chart's image
aTyr Pharma
Price$5.31
Change-$0.03 (-0.56%)
Volume$891
Capitalization475.28M
Biora Therapeutics
Price$0.12
Change-$0.00 (-0.00%)
Volume$1.93K
CapitalizationN/A
ATYR vs BIORQ Comparison Chart in %
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIORQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. BIORQ commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and BIORQ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (ATYR: $5.34 vs. BIORQ: $0.12)
Brand notoriety: ATYR and BIORQ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 77% vs. BIORQ: 20%
Market capitalization -- ATYR: $475.28M vs. BIORQ: $0
ATYR [@Biotechnology] is valued at $475.28M. BIORQ’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileBIORQ’s FA Score has 1 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • BIORQ’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATYR and BIORQ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 4 TA indicator(s) are bullish while BIORQ’s TA Score has 5 bullish TA indicator(s).

  • ATYR’s TA Score: 4 bullish, 5 bearish.
  • BIORQ’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIORQ is a better buy in the short-term than ATYR.

Price Growth

ATYR (@Biotechnology) experienced а +8.10% price change this week, while BIORQ (@Biotechnology) price change was -14.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.58%. For the same industry, the average monthly price growth was +8.83%, and the average quarterly price growth was +12.82%.

Reported Earning Dates

ATYR is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+1.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR YTD gains are higher at: 47.514 vs. BIORQ (-37.838).
ATYRBIORQATYR / BIORQ
Capitalization475MN/A-
EBITDA-65.9MN/A-
Gain YTD47.514-37.838-126%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash76.3MN/A-
Total Debt13MN/A-
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRBIORQ
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 29 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIORQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVNM66.480.43
+0.65%
Avantis All International Mkts Eq ETF
EEMX38.290.08
+0.20%
SPDR® MSCI Em Mkts Fssl Ful Free RsrvETF
BALT32.380.04
+0.11%
Innovator Defined Wealth Shld ETF
XTJL36.46N/A
N/A
Innovator US Equity Acclrtd Pls ETF Jul
JHCP25.01N/A
N/A
JHancock Core Plus Bond ETF

BIORQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIORQ has been closely correlated with HURA. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIORQ jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIORQ
1D Price
Change %
BIORQ100%
N/A
HURA - BIORQ
71%
Closely correlated
-1.50%
BIVI - BIORQ
31%
Poorly correlated
-21.17%
CMND - BIORQ
26%
Poorly correlated
-2.03%
ATYR - BIORQ
23%
Poorly correlated
+2.30%
CRVO - BIORQ
23%
Poorly correlated
-3.58%
More